RecruitingNot ApplicableNCT07087587

Sleep Apnea Triggers of Atrial Fibrillation: N-of-1 Randomized Control Trial (SPARTA):


Sponsor

The Cleveland Clinic

Enrollment

20 participants

Start Date

Aug 25, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

A pilot N-of-1 randomized controlled trial evaluating the effectiveness of a personalized CPAP intervention in reducing atrial fibrillation (AF) burden and improving AF-related quality of life in patients with moderate to severe obstructive sleep apnea (OSA).


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study (SPARTA) investigates whether treating sleep apnea — a condition where breathing repeatedly stops during sleep — can reduce episodes of atrial fibrillation (an irregular heart rhythm). It uses an N-of-1 design, meaning each participant acts as their own control at different times. **You may be eligible if...** - You are between 18 and 85 years old - You have frequent episodes of paroxysmal atrial fibrillation (AF occurring in bursts, ≥1% burden) - You have been diagnosed with moderate-to-severe sleep apnea (AHI ≥ 15) - You have an implanted cardiac device that tracks heart rhythms - You are enrolled in remote cardiac monitoring **You may NOT be eligible if...** - You had AF ablation (procedure to correct AF) within the past 6 months - You have significant heart valve problems - You have severe daytime sleepiness that makes CPAP medically necessary right away Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECPAP

CPAP will be randomized 2 weeks on 2 weeks off for 12 weeks total


Locations(2)

Cleveland Clinic

Cleveland, Ohio, United States

University of Washington

Seattle, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07087587


Related Trials